Moseley Investment Management’s Idexx Laboratories IDXX Stock Holding History

Moseley Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Sell	545 -80	-13%	-$51.3K	0.1%	118
2025 Q4	$423K	Hold	625	–	–	0.13%	106
2025 Q3	$399K	Hold	625	–	–	0.12%	113
2025 Q2	$335K	Hold	625	–	–	0.12%	115
2025 Q1	$262K	Hold	625	–	–	0.1%	125
2024 Q4	$258K	Hold	625	–	–	0.1%	128
2024 Q3	$316K	Sell	625 -100	-14%	-$48.6K	0.13%	114
2024 Q2	$353K	Hold	725	–	–	0.16%	98
2024 Q1	$391K	Hold	725	–	–	0.19%	95
2023 Q4	$402K	Hold	725	–	–	0.22%	94
2023 Q3	$317K	Hold	725	–	–	0.19%	102
2023 Q2	$364K	Hold	725	–	–	0.21%	95
2023 Q1	$363K	Hold	725	–	–	0.24%	96
2022 Q4	$296K	Hold	725	–	–	0.21%	108
2022 Q3	$236K	Hold	725	–	–	0.17%	119
2022 Q2	$254K	Buy	725 +150	+26%	+$61.2K	0.18%	126
2022 Q1	$315K	Hold	575	–	–	0.17%	129
2021 Q4	$379K	Hold	575	–	–	0.17%	126
2021 Q3	$359K	Hold	575	–	–	0.18%	120
2021 Q2	$363K	Hold	575	–	–	0.18%	122
2021 Q1	$281K	Hold	575	–	–	0.16%	130
2020 Q4	$287K	Hold	575	–	–	0.17%	119
2020 Q3	$226K	Buy	+575	New	+$213K	0.16%	125
2019 Q2	–	Sell	-1,075	Closed	-$240K	–	129
2019 Q1	$240K	Buy	+1,075	New	+$222K	0.25%	111

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moseley Investment Management's IDXX Position: Q1 2026 in Review

Moseley Investment Management reduced its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, selling an estimated $51.3K and leaving 545 shares worth $306K. The position accounts for 0.1% of the portfolio, ranked #118.

Moseley Investment Management first reported a position in IDXX in Q1 2019 and has held it in 24 quarters since. The position peaked at $423K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Moseley Investment Management held 545 shares of Idexx Laboratories worth $306K as of Q1 2026.
Moseley Investment Management sold 80 Idexx Laboratories shares in Q1 2026, an estimated $51.3K.
Idexx Laboratories made up 0.1% of Moseley Investment Management's portfolio in Q1 2026, its #118 holding.
Moseley Investment Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 24 quarters since.
Moseley Investment Management's Idexx Laboratories position peaked at $423K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Moseley Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.